Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10473207rdf:typepubmed:Citationlld:pubmed
pubmed-article:10473207lifeskim:mentionsumls-concept:C0021968lld:lifeskim
pubmed-article:10473207lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:10473207lifeskim:mentionsumls-concept:C0009924lld:lifeskim
pubmed-article:10473207lifeskim:mentionsumls-concept:C0043309lld:lifeskim
pubmed-article:10473207lifeskim:mentionsumls-concept:C0037775lld:lifeskim
pubmed-article:10473207lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:10473207lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:10473207pubmed:issue8lld:pubmed
pubmed-article:10473207pubmed:dateCreated1999-10-13lld:pubmed
pubmed-article:10473207pubmed:abstractTextIn x-ray phototherapy of brain tumours, the tumour is loaded with iodine and exposed to kilovoltage x-rays. Due to the high photoelectric cross sections of iodine, substantial photoelectric interactions occur. The flux of photoelectrons, characteristic x-rays and Auger electrons produce a localized dose enhancement. A modified computed tomography scanner, CTRx, can be used both for tumour localization and delivery of the dose enhancement therapy. Monte Carlo methods were employed to simulate the treatment of iodinated brain tumours with a CTRx. The calculated results reveal the effect of tumour iodine concentration on dose distribution, the degree of skull bone sparing with the application of multiple arcs, and the homogeneity of tumour dose distribution versus iodine concentration. A comparison with 10 MV stereotactic radiosurgery treatment shows the potential of CTRx treatment relative to conventional treatment modalities.lld:pubmed
pubmed-article:10473207pubmed:languageenglld:pubmed
pubmed-article:10473207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473207pubmed:citationSubsetIMlld:pubmed
pubmed-article:10473207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473207pubmed:statusMEDLINElld:pubmed
pubmed-article:10473207pubmed:monthAuglld:pubmed
pubmed-article:10473207pubmed:issn0031-9155lld:pubmed
pubmed-article:10473207pubmed:authorpubmed-author:NormanAAlld:pubmed
pubmed-article:10473207pubmed:authorpubmed-author:SmathersJ BJBlld:pubmed
pubmed-article:10473207pubmed:authorpubmed-author:MesaA VAVlld:pubmed
pubmed-article:10473207pubmed:authorpubmed-author:SolbergT DTDlld:pubmed
pubmed-article:10473207pubmed:authorpubmed-author:DemarcoJ JJJlld:pubmed
pubmed-article:10473207pubmed:issnTypePrintlld:pubmed
pubmed-article:10473207pubmed:volume44lld:pubmed
pubmed-article:10473207pubmed:ownerNLMlld:pubmed
pubmed-article:10473207pubmed:authorsCompleteYlld:pubmed
pubmed-article:10473207pubmed:pagination1955-68lld:pubmed
pubmed-article:10473207pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:meshHeadingpubmed-meshheading:10473207...lld:pubmed
pubmed-article:10473207pubmed:year1999lld:pubmed
pubmed-article:10473207pubmed:articleTitleDose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents.lld:pubmed
pubmed-article:10473207pubmed:affiliationDepartment of Radiation Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095, USA.lld:pubmed
pubmed-article:10473207pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10473207pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10473207pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10473207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10473207lld:pubmed